Toolkit/EvoMining

EvoMining

Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

The supplied web research summary identifies EvoMining as an evolutionary genome-mining approach that complements mainstream biosynthetic gene cluster search tools and supports discovery of hidden biosynthetic chemistry.

Usefulness & Problems

No literature-backed usefulness or problem-fit explainer has been materialized for this record yet.

Published Workflows

Objective: Accelerate natural product drug discovery by combining sequence-based prospecting, analytical dereplication, curated reference resources, and downstream structure elucidation or library-generation workflows.

Why it works: The supplied evidence suggests that combining genome mining, dereplication, curated databases, and structural analysis narrows discovery space and reduces rediscovery and interpretation bottlenecks.

biosynthetic gene cluster predictionmass-spectrometry-based dereplicationmolecular networkingreference-database-guided annotationstructure elucidationgenome miningmachine learningmass spectrometrymolecular networkingdatabase curationmetagenomic discovery

Stages

  1. 1.
    Genome mining and biosynthetic gene cluster prediction(in_silico_filter)

    The supplied evidence presents genome mining as an enabling early discovery technology for identifying candidate natural product chemistry from sequence data.

    Selection: Predicted biosynthetic gene clusters and candidate access to new natural-product chemical space

  2. 2.
    MS-based dereplication and molecular networking(counter_screen)

    The supplied evidence frames dereplication as a way to filter known chemistry and organize analytical data before deeper investment.

  3. 3.
    Reference-database-guided annotation(secondary_characterization)

    The supplied evidence identifies curated resources as useful for interpreting genome-mining and compound-discovery results.

    Selection: Comparison against curated biosynthetic gene cluster and natural product knowledge bases

  4. 4.
    Structure elucidation follow-up(confirmatory_validation)

    The supplied evidence highlights MicroED as a technology that can reduce structure elucidation bottlenecks in natural product discovery.

    Selection: Resolve candidate structures for prioritized natural products

Taxonomy & Function

Primary hierarchy

Technique Branch

Method: A concrete computational method used to design, rank, or analyze an engineered system.

Target processes

No target processes tagged yet.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1tool role summarysupports2021Source 1needs review

antiSMASH, DeepBGC, and EvoMining are presented in the supplied evidence as genome-mining approaches relevant to biosynthetic gene cluster discovery in natural product research.

Claim 2tool role summarysupports2021Source 1needs review

GNPS and DEREPLICATOR+ are presented in the supplied evidence as analytical and dereplication tools for mass-spectrometry-based natural product discovery.

Claim 3tool role summarysupports2021Source 1needs review

MIBiG and The Natural Products Atlas are presented in the supplied evidence as curated reference resources that support interpretation and normalization in natural product discovery.

Approval Evidence

1 source1 linked approval claimfirst-pass slug evomining
The supplied web research summary identifies EvoMining as an evolutionary genome-mining approach that complements mainstream biosynthetic gene cluster search tools and supports discovery of hidden biosynthetic chemistry.

Source:

tool role summarysupports

antiSMASH, DeepBGC, and EvoMining are presented in the supplied evidence as genome-mining approaches relevant to biosynthetic gene cluster discovery in natural product research.

Source:

Comparisons

No literature-backed comparison notes have been materialized for this record yet.

Ranked Citations

  1. 1.
    StructuralSource 1Nature Reviews Drug Discovery2021Claim 1Claim 2Claim 3

    Extracted from this source document.